| Name | CD63 antigen | ||
| UniProt ID | CD63_HUMAN | ||
| Gene Name | CD63 | ||
| Gene ID | 967 | ||
| Synonyms |
CD63, AD1, HOP-26, ME491, MLA1, OMA81H, Pltgp40, TSPAN30
|
||
| Sequence |
MAVEGGMKCVKFLLYVLLLAFCACAVGLIAVGVGAQLVLSQTIIQGATPGSLLPVVIIAV
GVFLFLVAFVGCCGACKENYCLMITFAIFLSLIMLVEVAAAIAGYVFRDKVMSEFNNNFR QQMENYPKNNHTASILDRMQADFKCCGAANYTDWEKIPSMSKNRVPDSCCINVTVGCGIN FNEKAIHKEGCVEKIGGWLRKNVLVVAAAALGIAFVEVLGIVFACCLVKSIRSGYEVM |
||
| Pathway Map | MAP LINK | ||
| T.C. Number | 8.A.40.1.19 | ||
| KEGG ID | hsa967 | ||
| Pfam | PF00335; PF19529 | ||
| Pair Name | Shogaol, Gefitinib | |||
| Phytochemical | Shogaol | |||
| Drug | Gefitinib | |||
| Disease Info | [ICD-11: 2C73] | Ovarian Cancer | Investigative | |
| Regulate Info | Up-regulation | CD63 antigen | Expression | |
| Result | Our results suggest that 6-shogaol exerts a potential anti-cancer effect in ovarian cancer and combination treatment with 6-shogaol and gefitinib may provide a novel anti-tumor therapeutic strategy in gefitinib-resistant ovarian cancer. | |||
